UP TO DATA CONTACT

Please feel free to contact us through the Contact Form below, send us an email, or give us a call. We respond to all inquiries within 24 hours on business days to support your lab effectively and efficiently.

UP TO DATA CONTACT

Please feel free to contact us through the contact form below, send us an email, or give us a call. We respond to all inquiries within 24 hours on business days to support your lab effectively and efficiently.

up to data Contact | Stylized illustration of two people having video conference call between computer and mobile device with chat bubbles and decorative leaves on transparent background

Get In Touch With Our
Expert Team

Looking for support with your research and data analysis? Our team has the experience and expertise to help you get the results you need.

up to data GmbH
(Europe)

Energie-Allee 1
55286 Woerrstadt
Germany

up to data LLC
(USA)

1346 How Ln North Brunswick Township
NJ 08902, USA

Phone

+49 6732 9490-0
(Europe)
+1 732 417 3601
(USA)

We’re Just a Message Away!

Ready to discuss your project? We’d love to learn more about your research goals and how we can help you achieve faster, more impactful results.

About up to data

up to data, founded in 1992, is an international provider of innovative, customisable IT solutions for the life sciences, pharmaceutical, chemical and biotech industries. We have offices in Europe, North America and the Asia-Pacific region.
Our product range includes lab data management and data review applications, as well as report writing solutions. Our innovative data management platform, StudyGen 360, enables us to be a highly specialised provider of study data management and GxP-compliant study reporting solutions that meet pharmaceutical regulatory requirements.
Whether you are working on early-stage drug development, vaccine research or stability studies, up to data delivers solutions that integrate seamlessly into existing working environments and support individual processes. Our automated workflows significantly improve time-to-market.